Stock Track | MEDBOT-B Soars 6.32% Intraday on Strong Annual Results Showing Revenue More Than Doubles

Stock Track05-04 09:47

MEDBOT-B (MicroPort MedBot-B) soared 6.32% intraday on Monday, reflecting strong investor sentiment following the company's latest financial disclosures.

The surge comes after the company recently disclosed its annual results, reporting revenue of approximately 551 million RMB, representing a year-over-year increase of over 114%. Gross profit surged significantly, and the pre-tax loss narrowed by more than 60%, indicating improved operational efficiency and financial health.

Core products including the Toumai laparoscopic surgical robot, Honghu orthopedic surgical robot, and Dragonfly Eye electronic laparoscope continued to advance commercial installations. Overseas market expansion also accelerated, reflecting the company's progressively materializing commercialization capabilities as its robotic surgery platform scales.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment